Newsfile Corp
28 Sept 2026, 02:24 UTC · 1h ago
AARD DEADLINE: ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AARD
Verdict
Headline takes no side. We score AARD −1.00 across two claims — strongly bearish.
- Expected · AARD
−1.00strongly bearish
−1 bearish0bullish +1More negative than 95% of ticker scores this week





